There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

BY SYLVESTER OJENAGBON Chronic kidney disease is a significant public health concern in Nigeria. Studies show its ...

The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

The number of patients with chronic kidney disease is increasing with aging. According to the Health Insurance Review and Assessment Service, the number of patients with chronic kidney disease surged ...

Clinical trials suggesting that hemodiafiltration offers a survival benefit over hemodialysis have largely been conducted among the prevalent dialysis population, so investigators examined an incident ...